Gurkamal Chatta

Treatment recommendations to cancer patients in the context of FDA guidance for next generation sequencing

Sean T. Glenn, Blake Burgher, Carl Morrison, 2019, BMC Medical Informatics and Decision Making.

A phase II trial of the Src-kinase inhibitor AZD0530 in patients with advanced castration-resistant prostate cancer: a California Cancer Consortium study

Gurkamal Chatta, Christopher P Evans, D. Gandara, 2009, Anti-cancer drugs.

Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy

Gurkamal Chatta, G. Chatta, 2003 .